DUPONT CAPITAL MANAGEMENT CORP
Position in NAMS — NewAmsterdam Pharma Co N.V.
CIK 1128251
Wilmington, DE
Position in NAMS
as of Mar 31, 2026
· filed Apr 23, 2026
Position Value
$32
-$3 QoQ
Shares Held
1
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DUPONT CAPITAL MANAGEMENT CORP holds $305 across 3 Biotechnology names. NAMS ranks #3 (10.5% of the industry book) .
All Filings in NAMS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $32 | 1 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $35 | 1 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $28 | 1 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $18 | 1 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $20 | 1 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $25 | 1 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $16 | 1 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $19 | 1 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $23 | 1 | Shares | Sole | 2024-05-23 | |
| 2023-12-31 | $11 | 1 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $9 | 1 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $11 | 1 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $13 | 1 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $10 | 1 | Shares | Sole | 2023-01-26 | |
| No filing history on record for this holder in this stock. | ||||||